Alizaprid

Discover Alizaprid, an effective antiemetic medication used to prevent and treat nausea and vomiting. Learn about its uses, mechanism of action, dosage, an

Alizaprid Alizaprid uses Alizaprid mechanism of action Alizaprid side effects Alizaprid dosage Alizaprid for nausea Alizaprid antiemetic Alizaprid drug interactions
🏷 ATC Code: A03FA04 📂 Antiemetics and antinauseants 🕐 Updated: Mar 12, 2026 ✓ Medical Reference

Looking to order Alizaprid?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Alizaprid?

Alizaprid is a pharmaceutical agent primarily classified as an antiemetic, meaning it is used to prevent and treat nausea and vomiting. It belongs to the class of substituted benzamides, similar in structure to metoclopramide. This medication works by influencing specific receptors in the brain and gut that are involved in the sensation of nausea and the reflex of vomiting. While not as widely known globally as some other antiemetics, Alizaprid plays a crucial role in managing these distressing symptoms, particularly in specific clinical settings such as post-operative recovery or during certain medical treatments.

First synthesized several decades ago, Alizaprid has been utilized in various countries for its efficacy. Its primary action as a dopamine antagonist sets it apart, contributing to its unique therapeutic profile. Understanding its mechanism of action is key to appreciating its effectiveness and recognizing its potential side effects and interactions with other medications.

How Does it Work?

The antiemetic action of Alizaprid is primarily attributed to its ability to block dopamine D2 receptors. These receptors are densely located in the chemoreceptor trigger zone (CTZ) in the brain, an area that monitors the blood for toxins and sends signals to the vomiting center. By blocking these D2 receptors, Alizaprid effectively reduces the signals that trigger nausea and the vomiting reflex.

In addition to its D2 receptor antagonism, Alizaprid also exhibits some antagonistic effects on 5-HT3 (serotonin) receptors and weak agonistic effects on 5-HT4 receptors. While the D2 antagonism is considered its main mechanism for preventing vomiting, the additional serotonergic activity may contribute to its overall antiemetic and prokinetic (motility-enhancing) properties, particularly in the upper gastrointestinal tract. This dual action helps to not only suppress the central triggers of vomiting but also to improve gastric emptying, which can further alleviate nausea and prevent reflux.

Medical Uses

Alizaprid is indicated for the prevention and treatment of various types of nausea and vomiting. Its utility spans several medical scenarios:

  • Chemotherapy-Induced Nausea and Vomiting (CINV)

    One of the most significant applications of Alizaprid is in managing CINV, a common and often debilitating side effect of cancer treatment. It can be used both acutely to prevent vomiting immediately after chemotherapy and as a rescue medication for breakthrough nausea.

  • Post-Operative Nausea and Vomiting (PONV)

    Patients undergoing surgery frequently experience nausea and vomiting as a result of anesthesia, opioids, and the surgical procedure itself. Alizaprid can be administered to mitigate these post-operative symptoms, improving patient comfort and recovery.

  • Nausea and Vomiting Associated with Radiation Therapy

    Similar to chemotherapy, radiation therapy, especially to the abdomen, can induce significant gastrointestinal distress. Alizaprid helps to control these symptoms, allowing patients to better tolerate their treatment.

  • Nausea and Vomiting in Migraine

    Many individuals experiencing migraines also suffer from severe nausea and vomiting. Alizaprid can be effective in reducing these associated symptoms, often leading to better absorption of oral migraine medications.

  • Other Gastrointestinal Conditions

    In some cases, Alizaprid may be used to manage nausea and vomiting related to other gastrointestinal disorders, particularly where impaired gastric motility is a contributing factor.

Dosage

The dosage of Alizaprid varies significantly depending on the specific indication, the patient's age, weight, renal function, and the route of administration. Alizaprid is available in various forms, including oral tablets, intramuscular (IM) injections, and intravenous (IV) solutions.

  • General Guidelines

    For adults, common dosages range from 50 mg to 100 mg per administration. For severe cases, such as highly emetogenic chemotherapy-induced nausea, higher doses or more frequent administration might be prescribed, often in combination with other antiemetics.

  • Administration

    Intravenous administration is often preferred for acute and severe nausea and vomiting due to its rapid onset of action. Oral forms are typically used for less severe symptoms or for maintenance therapy.

  • Special Populations

    Dosage adjustments are usually necessary for patients with impaired renal function, as Alizaprid is primarily excreted by the kidneys. Elderly patients may also require lower doses due to potential increased sensitivity to side effects.

It is crucial that Alizaprid is administered strictly under the guidance of a healthcare professional, who will determine the appropriate dosage and duration of treatment.

Side Effects

Like all medications, Alizaprid can cause side effects, although not everyone experiences them. Most side effects are mild and transient, but some can be more serious.

  • Common Side Effects

    • Drowsiness or sedation
    • Dizziness
    • Headache
    • Fatigue
    • Diarrhea
  • Less Common but Potentially Serious Side Effects

    • Extrapyramidal symptoms (EPS): These are movement disorders that can include dystonia (involuntary muscle contractions), akathisia (restlessness), and parkinsonism (tremor, rigidity, bradykinesia). The risk of EPS is generally lower with Alizaprid compared to some other dopamine antagonists but still exists, especially at higher doses or in sensitive individuals.
    • Hypotension (low blood pressure)
    • QT prolongation: While rare, Alizaprid can potentially affect the heart's electrical activity, leading to a prolonged QT interval, which can increase the risk of serious arrhythmias.
    • Allergic reactions: Rash, itching, swelling, or severe dizziness.

Patients should report any unusual or persistent side effects to their doctor immediately.

Drug Interactions

Alizaprid can interact with several other medications, which may alter its effects or increase the risk of side effects. It is essential to inform your healthcare provider about all prescription, over-the-counter, and herbal supplements you are taking.

  • CNS Depressants

    Concurrent use with other central nervous system (CNS) depressants, such as alcohol, opioids, sedatives, anxiolytics, and antihistamines, can enhance the sedative effects of Alizaprid, leading to increased drowsiness and impaired coordination.

  • Anticholinergic Drugs

    Anticholinergic medications (e.g., atropine, certain antidepressants) may antagonize the prokinetic effects of Alizaprid, reducing its ability to improve gastric motility.

  • Dopaminergic Agonists

    Alizaprid, being a dopamine antagonist, can reduce the efficacy of dopaminergic agonists used to treat Parkinson's disease (e.g., levodopa), potentially worsening Parkinsonian symptoms.

  • Drugs that Prolong QT Interval

    Caution is advised when Alizaprid is co-administered with other drugs known to prolong the QT interval (e.g., certain antiarrhythmics, antipsychotics, antibiotics, and antidepressants), as this combination may increase the risk of cardiac arrhythmias.

FAQ

  • Is Alizaprid the same as metoclopramide?

    While both Alizaprid and metoclopramide are substituted benzamides and act as dopamine antagonists, they are distinct compounds with some differences in their pharmacological profiles, potency, and side effect incidence. They are used for similar indications but are not interchangeable without medical advice.

  • Can Alizaprid be used during pregnancy or breastfeeding?

    The use of Alizaprid during pregnancy and breastfeeding should be approached with caution. It should only be used if the potential benefit outweighs the potential risks to the fetus or infant. Always consult a healthcare professional for advice.

  • How quickly does Alizaprid work?

    When administered intravenously, Alizaprid can start to work within minutes. Oral forms may take longer, typically within 30-60 minutes, to exert their effects.

  • Is Alizaprid addictive?

    No, Alizaprid is not considered an addictive substance.

  • What precautions should be taken with Alizaprid?

    Precautions include careful use in patients with renal impairment, elderly individuals, those with a history of movement disorders, or individuals at risk of QT prolongation. Monitoring for side effects, especially extrapyramidal symptoms, is important.

Products containing Alizaprid are available through trusted online pharmacies. You can browse Alizaprid-based medications at ShipperVIP or Medicenter.

Summary

Alizaprid is an effective antiemetic medication primarily used to prevent and treat nausea and vomiting induced by various factors, including chemotherapy, surgery, and radiation therapy. Its mechanism of action involves blocking dopamine D2 receptors in the brain's chemoreceptor trigger zone, with some additional serotonergic activity. While generally well-tolerated, it can cause side effects such as drowsiness and, less commonly, extrapyramidal symptoms. Due to potential drug interactions and the need for individualized dosing, Alizaprid should always be used under the supervision of a healthcare professional. Its role remains vital in alleviating distressing symptoms and improving the quality of life for patients undergoing challenging medical treatments.